SunLink and Regional shareholders approve merger; closing subject to conditions

SUNLINK HEALTH SYSTEMS INC

SunLink shareholders voted 4,058,928 for, 95,916 against the merger; advisory compensation proposal also passed.
Regional shareholders approved issuance of common stock and Series D 8% cumulative convertible preferred shares.
Merger remains subject to customary closing conditions; no effective date announced.
Joint press release issued August 4, 2025 confirming both special meeting approvals.

item 5.07item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.